Literature DB >> 18344842

Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia.

Marieke A D van Zoelen1, Akitoshi Ishizaka, Esther K Wolthuls, Goda Choi, Tom van der Poll, Marcus J Schultz.   

Abstract

High-mobility group box (HMGB) 1 is a recently discovered proinflammatory mediator that contributes to acute lung injury. We determined HMGB-1 levels in bronchoalveolar lavage fluid of patients during mechanical ventilation (MV) and ventilator-associated pneumonia (VAP). Bronchoalveolar lavage fluid was obtained from patients who were ventilated for 5 h because of an elective surgical procedure ("short-term MV"; n = 40) or for several days because of respiratory failure without acute lung injury ("long-term MV"; n = 10) and from patients who developed unilateral VAP (n = 4). Ten healthy volunteers served as controls. In healthy volunteers, HMGB-1 levels were low (median, 1.6 ngmL(-1); interquartile range [IQR], 0.7-3.7 ng mL(-1)). Although HMGB-1 levels were elevated after short-term MV, differences were not statistically significant compared with healthy volunteers (1.7 ng mL(-1); IQR, 0.8-8.5 ng mL(-1), P = 0.493 vs. healthy volunteers; P = 0.250 vs. start of MV). However, HMGB-1 levels were significantly higher in "long-term" MV patients (11.7 ng mL(-1); IQR, 8.7-37.0 ng mL(-1); P < 0.0001 vs. healthy volunteers). With unilateral VAP, HMGB-1 levels from the infected lung.were 17.4 (IQR, 8.5-23.2) ng mL(-1) (P = 0.014 vs. healthy controls); these levels were not different from those measured in the contralateral noninfected lung (P = 0.625). Summarized, long-term MV is associated with increased HMGB-1 levels in contrast to "short-term" MV. In addition, HMGB-1 levels during VAP are increased compared with healthy volunteers; however, they are not different from those found in patients intubated and mechanically ventilated for a similar period of time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344842     DOI: 10.1097/SHK.0b013e318157eddd

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  37 in total

Review 1.  The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.

Authors:  Weidun Alan Guo; Paul R Knight; Krishnan Raghavendran
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

2.  High mobility group box 1 protein in bronchoalveolar lavage fluid and correlation with other inflammatory markers in pulmonary diseases.

Authors:  Magda Suchankova; Vladimira Durmanova; Elena Tibenska; Eva Tedlova; Ivan Majer; Helena Novosadova; Juraj Demian; Miroslav Tedla; Maria Bucova
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo.

Authors:  Forrest Jessop; Andrij Holian
Journal:  Nanotoxicology       Date:  2014-07-01       Impact factor: 5.913

4.  Hyperoxia, HMGB1, and ventilator-associated pneumonia: reducing risk by practicing what we teach.

Authors:  Thomas P Kennedy; Steve Nelson
Journal:  Am J Respir Cell Mol Biol       Date:  2013-03       Impact factor: 6.914

Review 5.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

Review 6.  The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness.

Authors:  Kevin C Ma; Edward J Schenck; Maria A Pabon; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

7.  HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development.

Authors:  Kiyoshi Kikuchi; Hisaaki Uchikado; Naoki Miura; Yoko Morimoto; Takashi Ito; Salunya Tancharoen; Kei Miyata; Rokudai Sakamoto; Chiemi Kikuchi; Narumi Iida; Naoto Shiomi; Terukazu Kuramoto; Naohisa Miyagi; Ko-Ichi Kawahara
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

8.  HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans.

Authors:  Erik D Peltz; Ernest E Moore; Phillip C Eckels; Sagar S Damle; Yuko Tsuruta; Jeffrey L Johnson; Angela Sauaia; Christopher C Silliman; Anirban Banerjee; Edward Abraham
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

9.  Ascorbic Acid Attenuates Hyperoxia-Compromised Host Defense against Pulmonary Bacterial Infection.

Authors:  Vivek S Patel; Vaishali Sampat; Michael Graham Espey; Ravikumar Sitapara; Haichao Wang; Xiaojing Yang; Charles R Ashby; Douglas D Thomas; Lin L Mantell
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.